The Israeli government has published an Approach to Market in order to get information from professionals in order to examine a framework for building a vaccine manufacturing infrastructure in Israel, allowing the state to attain vaccine independence.
According to the government currently, Israel is fully reliant on foreign vaccines in the event of an epidemic or pandemic. In such situations, establishing an independent capability to research, manufacture, and license vaccines in Israel is critical in order to combat known infections (such as influenza and COVID-19) or unknown viruses that could have a catastrophic impact on Israel’s public health and economy.
Following receipt of responses, the State will determine its subsequent steps
Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.
